Research map: A decade in inflammatory bowel disease: progress, plateaus, and perspectives

Back to the article

Papers in this map

  1. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD · Dan Turner · 2021 · 2888 citations · Cited by this paper
  2. Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial · 2026 · Related
  3. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease · Oxford IBD Cohort Investigators · 2017 · 840 citations · Cited by this paper
  4. Ethnicity, diversity, and inclusion in gastroenterology: from representation to system performance · 2026 · Related
  5. Global evolution of inflammatory bowel disease across epidemiologic stages · Lindsay Hracs · 2025 · 441 citations · Cited by this paper
  6. Cyclic exclusive enteral nutrition in paediatric Crohn's disease – Authors’ reply · 2026 · Related
  7. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial · Cyriel Y. Ponsioen · 2017 · 368 citations · Cited by this paper
  8. Rome V: refining the language of gut–brain disorders · 2026 · Related
  9. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial · Nurulamin M Noor · 2024 · 305 citations · Cited by this paper
  10. The spectrum of steatotic liver disease in the USA – Authors’ reply · 2026 · Related
  11. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity · Mathieu Uzzan · 2022 · 265 citations · Cited by this paper
  12. Drugging the undruggable in pancreatic cancer · 2026 · Related
  13. Understanding the therapeutic toolkit for inflammatory bowel disease · Sophie Vieujean · 2025 · 167 citations · Cited by this paper
  14. Pathophysiology of irritable bowel syndrome · 2026 · Related
  15. Location is important: differentiation between ileal and colonic Crohn’s disease · Raja Narayana Atreya · 2021 · 148 citations · Cited by this paper
  16. Translating the gut microbiome: where are we? · 2026 · Related
  17. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1 · Torsten F. Kucharzik · 2025 · 123 citations · Cited by this paper
  18. Therapeutic drift or formulation drift: avoiding misconceptions about rifaximin and antimicrobial resistance in cirrhosis · 2026 · Related
  19. A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice · Dominik Bettenworth · 2024 · 81 citations · Cited by this paper
  20. Combination therapy in metabolic dysfunction-associated steatohepatitis · 2026 · Related
  21. European Crohn’s and Colitis Organisation consensus on dietary management of inflammatory bowel disease · Vaios Svolos · 2025 · 62 citations · Cited by this paper
  22. CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis · Fabian Müller · 2025 · 56 citations · Cited by this paper

Source: OpenAlex (CC0)